The mycobacteria are aerobic rod-shaped organisms characterized by being acid fast and by their very slow growth rate. Mycobacteria are of great importance in human and veterinary medicine and have reemerged as a serious health problem worldwide. There are at least 25 Mycobacterium species, with M. tuberculosis and species within the M. avium complex being the most common isolates in clinical laboratories in the United States (5, 8) . In developing countries, tuberculosis remains a major problem, causing an estimated annual death rate of greater than 2,500,000 (2) . The detection and identification of mycobacteria to the species level have been fraught with both low sensitivity and a long turnaround time, leading to significant delays in diagnosis. To improve upon the detection of mycobacteria, methods utilizing the amplification of mycobacterial DNA by the polymerase chain reaction (PCR) coupled with Southern blotting have been developed (1, 3, 4, 6, 7, 9, 10) . However, these methods are not yet suitable for routine use in the clinical laboratory because of the rigorous methods required and the need to use radioactive isotopes.
We sought to develop a method which used the sensitivity of DNA amplification, did not require radioisotopes, and was amenable to use in a clinical laboratory. This paper describes such a method using nonradioactive reverse dot blot hybridization, adapted from the method originally described for the detection of human genetic polymorphisms (13) . Primers were chosen to amplify and label DNA from all species of mycobacteria. Internal probes designed to differentiate the species were fixed to a nylon membrane support. The amplified product was used for the hybridization reaction with the strips containing the spotted series of speciesspecific probes. (Fig. 1B) . (Fig. 2B, strips 3 to 5) and two hybridized with neither probe (Fig. 2B, strip 2 , one of the two isolates). Increasing the stringency of the washing step after hybridization did not eliminate the cross-hybridization of TB4 with the three M. avium complex isolates. The two M. avium complex isolates which did not hybridize with either probe were also not detected with the SNAP probe for the M. avium complex. These isolates were further examined by biochemical methods and identified as M. xenopi.
The hybridization results of the three M. avium complex isolates that reacted with TB4 were further examined. DNA from M. avium ATCC 25291, M. intracellulare ATCC 13950 and ATCC 35770, and M. tuberculosis ATCC 25177 were amplified and tested by reverse dot blot. Whereas the M. avium DNA hybridized with TB5 only and the M. tuberculosis DNA hybridized with TB4 only, the two M. intracellulare DNAs hybridized with TB4 and not with TB5. This suggested that the three M. avium complex clinical isolates which hybridized with the M. tuberculosis probe were in fact M. intracellulare and that TB4 cross-hybridized with 
CTG CTC AAG GGC GCC AAG GAG GTC GAG ACC AAG GAG CAG ATT GCG 241 ---------------------- M. intracellulare. To verify this possibility, additional primers and probes were constructed by using 16S rRNA sequences which were specific for M. avium, M. intracellulare, and M. tuberculosis; the three M. avium complex isolates which hybridized with probe TB4 hybridized with the probe for the 16S rRNA sequence of M. intracellulare (3a) .
To further investigate the cross-reactivity of the M. intracellulare isolates with TB4, the DNA sequences of the amplified products were determined from M. intracellulare ATCC 13950 and M. tuberculosis ATCC 25177 (Fig. 3) . In the region of TB4 and TB5 hybridization, the sequence for M. avium differed from M. tuberculosis by 5 out of 20 nucleotides, whereas the sequence for M. intracellulare differed from M. tuberculosis by 2 nucleotides. DISCUSSION A method is described for the rapid identification of an array of mycobacterial species by PCR and the chemiluminescent detection of species-specific DNA sequences with reverse dot blot hybridization. The format of the assay was readily applicable for implementation in the clinical laboratory. The assay required no radioactivity and had a fast turnaround time of 1 PCR sequencing of the amplified 383-bp product from M. tuberculosis and M. intracellulare revealed nucleotide substitutions encompassing the region of both the TB4 and TB5 probes. The probes on the reverse dot blot strip were designed to discriminate single-base-pair changes. Although DNA sequencing revealed that the TB4 probe differed by two nucleotides from the M. intracellulare sequence, the hybridization was not affected because the substitution that occurred at the 3' end of the probe did not result in sufficient thermal instability to affect hybridization. The second substitution at position 250 (A to G) was stabilized by the nature of the mismatch (G:T) which could form stable hydrogen bonding between the two nucleotides. Such mismatches are stable and can often result in cross-hybridization.
There were two additional unexpected results from this study. The first was that the probe for M. avium, TB5, hybridized with the two M. scrofulaceum isolates tested, suggesting that TB5 lacked adequate specificity. The second unexpected finding was that the two isolates which did not hybridize with either the probe for M. tuberculosis or the probe for M. avium were both misidentified. These isolates had been initially identified as M. avium complex isolates but were reidentified with additional biochemical testing as M. xenopi. M. xenopi and M. avium are difficult to distinguish by biochemical testing, leading to the misidentification of M. xenopi. It is possible that other M. avium complex isolates originally reported to be nonhybridizing in commercial DNA probe tests were in fact M. xenopi.
This study examined the identification of mycobacteria to the species level on the basis of reverse dot blot analysis with amplified mycobacterial DNA. This technique will be useful in the identification of mycobacteria to the species level. Since both probes TB4 and TB5 were designed from the sequencing of single isolates, it was important to test the sensitivity of these probes with multiple isolates. In future studies it will be important to design probes for hybridization after sequencing appropriate regions of DNA from a large number of isolates from multiple species, thus eliminating the possibility of cross-hybridization or low sensitivity.
The ultimate goal for application of the reverse dot blot technology with amplified mycobacterial DNA is the direct detection of mycobacterial infection, providing rapid diagnosis and circumventing the need for culture. The data in our paper have demonstrated the feasibility of this application.
